Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
ETON — Eton Pharmaceuticals, Inc.
NASDAQ
FULL STOCK PAGE →

Q4 2025 Earnings Call Summary

MAR 19, 2026
REVENUE
$21.3M -5.2%
NET MARGIN
7.0% +15.5 PTS
EPS
$0.06 +178.6%
FREE CASH FLOW
-$11.6M -198.8%

No summary has been written for this call yet.